PE20040321A1 - Composicion topica que comprende diclofenaco - Google Patents
Composicion topica que comprende diclofenacoInfo
- Publication number
- PE20040321A1 PE20040321A1 PE2003000846A PE2003000846A PE20040321A1 PE 20040321 A1 PE20040321 A1 PE 20040321A1 PE 2003000846 A PE2003000846 A PE 2003000846A PE 2003000846 A PE2003000846 A PE 2003000846A PE 20040321 A1 PE20040321 A1 PE 20040321A1
- Authority
- PE
- Peru
- Prior art keywords
- diclofenaco
- composition including
- topical composition
- agent selected
- glycol
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 title abstract 2
- 230000000699 topical effect Effects 0.000 title 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 abstract 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 229920002125 Sokalan® Polymers 0.000 abstract 1
- 229910021529 ammonia Inorganic materials 0.000 abstract 1
- 239000003429 antifungal agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 239000003349 gelling agent Substances 0.000 abstract 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000002736 nonionic surfactant Substances 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- NOJNFULGOQGBKB-UHFFFAOYSA-M sodium;3-[3-tert-butylsulfanyl-1-[[4-(6-ethoxypyridin-3-yl)phenyl]methyl]-5-[(5-methylpyridin-2-yl)methoxy]indol-2-yl]-2,2-dimethylpropanoate Chemical compound [Na+].C1=NC(OCC)=CC=C1C(C=C1)=CC=C1CN1C2=CC=C(OCC=3N=CC(C)=CC=3)C=C2C(SC(C)(C)C)=C1CC(C)(C)C([O-])=O NOJNFULGOQGBKB-UHFFFAOYSA-M 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
QUE COMPRENDE: A)DE 0,02% A 0,4% DE SAL SODICA DE DICLOFENACO; B)AL MENOS 50% DE AGUA; C)DE 0% A 30% DE UN ALCANOL DE 2 A 4 ATOMOS DE CARBONO; D)DE 3% A 20% DE UN SOLVENTE DE GLICOL SELECCIONADO DE PROPILENGLICOL Y POLIETILENGLICOL (200 A 20 000); E)DE 0,2% A 3% DE POR LO MENOS UN AGENTE GELIFICANTE SELECCIONADO DE CARBOMEROS; F)DE 2% A 8% DE AL MENOS UN LIPIDO, QUE FORME LA FASE OLEOSA DEL GEL EN EMULSION; G)DE 1% A 5% DE AL MENOS UN TENSOACTIVO NO IONICO; Y, H)UN AGENTE BASICO SELECCIONADO DE: AMONIACO, HIDROXIDO DE SODIO E HIDROXIDO DE POTASIO, PARA AJUSTAR EL pH DE LA COMPOSICION TOTAL A UN RANGO DE 6,5 A 8. DONDE, LA COMPOSICION ESTA EXENTA DE UN FARMACO ANTIFUNGICO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02018772 | 2002-08-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20040321A1 true PE20040321A1 (es) | 2004-07-15 |
Family
ID=31896841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003000846A PE20040321A1 (es) | 2002-08-22 | 2003-08-20 | Composicion topica que comprende diclofenaco |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US7732489B2 (es) |
| EP (1) | EP1536836B1 (es) |
| AR (1) | AR041021A1 (es) |
| AT (1) | ATE390149T1 (es) |
| AU (1) | AU2003264086B2 (es) |
| BR (1) | BR0313701A (es) |
| CA (1) | CA2496469C (es) |
| DE (1) | DE60319997T2 (es) |
| DK (1) | DK1536836T3 (es) |
| ES (1) | ES2300645T3 (es) |
| MX (1) | MXPA05002077A (es) |
| PE (1) | PE20040321A1 (es) |
| PT (1) | PT1536836E (es) |
| SI (1) | SI1536836T1 (es) |
| TW (1) | TWI316857B (es) |
| WO (1) | WO2004017998A2 (es) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1588697A1 (en) * | 2004-04-16 | 2005-10-26 | Kurt H. Prof. Dr. Bauer | Emulsion gel for topical application of pharmaceuticals |
| FR2882552B1 (fr) * | 2005-02-25 | 2008-12-26 | Galderma Sa | Gel aqueux de haute stabilite a base de metronidazole et procedes pour leur preparation |
| WO2006116661A2 (en) * | 2005-04-27 | 2006-11-02 | Avocet Polymer Technologies, Inc. | Polyethylene glycol based composition for topical treatment of a closed wound with therapeutic pharmaceuticals |
| JP2010502764A (ja) | 2006-09-11 | 2010-01-28 | バイオマス リミテッド | テルル含有化合物の局所製剤 |
| CN101588791A (zh) | 2006-10-17 | 2009-11-25 | 纽沃研究公司 | 双氯芬酸凝胶 |
| GB0704846D0 (en) * | 2007-03-13 | 2007-04-18 | Futura Medical Dev Ltd | Topical pharmaceutical formulation |
| DE102007034976A1 (de) | 2007-07-26 | 2009-01-29 | Bayer Healthcare Ag | Arzneimittel zur transdermalen Anwendung bei Tieren |
| EP2055298A1 (en) * | 2007-10-30 | 2009-05-06 | Novartis AG | Topical composition |
| US20100099766A1 (en) * | 2008-10-16 | 2010-04-22 | Novartis Ag | Topical NSAID compositions having sensate component |
| US20100100060A1 (en) * | 2008-10-17 | 2010-04-22 | Novartis Ag | Applicator for pharmaceutical product and method of using same |
| DE102009008094A1 (de) * | 2009-02-09 | 2010-08-19 | Barnikol-Keuten, Doris, Dr. | In situ Haft-Gelbildende Zubereitungen, insbesondere zur topischen Anwendung auf befeuchtete Haut/Schleimhaut |
| US8618164B2 (en) | 2009-03-31 | 2013-12-31 | Nuvo Research Inc. | Treatment of pain with topical diclofenac compounds |
| US8546450B1 (en) | 2009-03-31 | 2013-10-01 | Nuvo Research Inc. | Treatment of pain with topical diclofenac compounds |
| EP2416759A2 (en) | 2009-04-08 | 2012-02-15 | Cadila Healthcare Limited | Stable pharmaceutical compositions of diclofenac |
| MX352187B (es) * | 2009-12-16 | 2017-11-13 | Shasun Pharmaceuticals Ltd Star | Composición novedosa de hidrogel transdérmico de dexibuprofeno. |
| US9713590B2 (en) | 2011-07-28 | 2017-07-25 | Cadila Healthcare Limited | Method for treatment of pain and inflammation |
| ITMI20121205A1 (it) | 2012-07-11 | 2014-01-12 | Glycores 2000 Srl | Composizione con attivita' antinfiammatoria ed analgesica da somministrare per uso esterno mediante vaporizzazione |
| JP6259454B2 (ja) * | 2012-07-12 | 2018-01-10 | フェリング ベスローテン フェンノートシャップ | ジクロフェナク製剤 |
| CN111904926B (zh) | 2014-09-10 | 2023-10-10 | Gsk消费者健康有限责任公司 | 局部用双氯芬酸钠组合物 |
| GB201502845D0 (en) * | 2015-02-20 | 2015-04-08 | Futura Medical Dev Ltd | Topical pharmaceutical formulation |
| JP6598619B2 (ja) * | 2015-09-28 | 2019-10-30 | 株式会社ポーラファルマ | 物性で特定される皮膚外用剤 |
| FR3064495B1 (fr) | 2017-03-31 | 2021-04-02 | Total Marketing Services | Composition a base d'uree pour le traitement des gaz d'echappement |
| KR20240067245A (ko) | 2021-10-01 | 2024-05-16 | 뉴트리션 ＆ 바이오사이언시즈 유에스에이 1, 엘엘씨 | 국소 적용을 위한 하이드로콜로이드 블렌드 조성물 |
| WO2023180792A1 (en) | 2022-03-25 | 2023-09-28 | Glycores 2000 Srl | Topical pharmaceutical composition with anti-inflammatory and analgesic activity and uses thereof |
| US20250099369A1 (en) | 2023-09-27 | 2025-03-27 | Andros Pharmaceuticals Co., Ltd. | Topical delivery compositions comprising non-steroidal anti-inflammatory drugs |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH655656B (es) * | 1982-10-07 | 1986-05-15 | ||
| CA2058975C (en) | 1990-10-30 | 2000-06-06 | Shuichi Kasai | Antiinflammatory gel preparation |
| EP0592569A1 (en) * | 1991-07-03 | 1994-04-20 | Sano Corporation | Composition and method for transdermal delivery of diclofenac |
| US5399342A (en) * | 1993-02-03 | 1995-03-21 | Dow Corning Corporation | Cosmetics with enhanced durability |
| WO1997028794A1 (fr) * | 1996-02-07 | 1997-08-14 | Tsumura & Co. | Solution aqueuse transparente de diclofenac sodique, compositions medicinales, et utilisations |
| DE69819748T2 (de) * | 1997-09-12 | 2004-09-30 | Columbia Laboratories (Bermuda) Ltd. | Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen |
| TWI290464B (en) | 2000-09-01 | 2007-12-01 | Novartis Consumer Health Sa | Treatment of burns |
| GB0108082D0 (en) * | 2001-03-30 | 2001-05-23 | Novartis Consumer Health Sa | Topical composition |
-
2003
- 2003-08-20 PE PE2003000846A patent/PE20040321A1/es active IP Right Grant
- 2003-08-20 AR ARP030103005A patent/AR041021A1/es not_active Application Discontinuation
- 2003-08-21 AT AT03792412T patent/ATE390149T1/de active
- 2003-08-21 MX MXPA05002077A patent/MXPA05002077A/es active IP Right Grant
- 2003-08-21 DK DK03792412T patent/DK1536836T3/da active
- 2003-08-21 DE DE60319997T patent/DE60319997T2/de not_active Expired - Lifetime
- 2003-08-21 TW TW092123045A patent/TWI316857B/zh not_active IP Right Cessation
- 2003-08-21 US US10/524,735 patent/US7732489B2/en not_active Expired - Lifetime
- 2003-08-21 CA CA2496469A patent/CA2496469C/en not_active Expired - Fee Related
- 2003-08-21 WO PCT/EP2003/009302 patent/WO2004017998A2/en not_active Ceased
- 2003-08-21 SI SI200331225T patent/SI1536836T1/sl unknown
- 2003-08-21 PT PT03792412T patent/PT1536836E/pt unknown
- 2003-08-21 AU AU2003264086A patent/AU2003264086B2/en not_active Ceased
- 2003-08-21 EP EP03792412A patent/EP1536836B1/en not_active Expired - Lifetime
- 2003-08-21 ES ES03792412T patent/ES2300645T3/es not_active Expired - Lifetime
- 2003-08-21 BR BR0313701-5A patent/BR0313701A/pt active Search and Examination
-
2010
- 2010-05-12 US US12/778,322 patent/US8557870B2/en not_active Expired - Fee Related
-
2013
- 2013-10-14 US US14/053,176 patent/US8716340B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE60319997T2 (de) | 2009-04-30 |
| ATE390149T1 (de) | 2008-04-15 |
| US8716340B2 (en) | 2014-05-06 |
| WO2004017998A3 (en) | 2004-04-01 |
| CA2496469C (en) | 2011-07-05 |
| PT1536836E (pt) | 2008-05-09 |
| AU2003264086A1 (en) | 2004-03-11 |
| ES2300645T3 (es) | 2008-06-16 |
| DE60319997D1 (de) | 2008-05-08 |
| WO2004017998A2 (en) | 2004-03-04 |
| AU2003264086B2 (en) | 2007-01-04 |
| TWI316857B (en) | 2009-11-11 |
| US8557870B2 (en) | 2013-10-15 |
| US20140045942A1 (en) | 2014-02-13 |
| SI1536836T1 (sl) | 2008-08-31 |
| US20100234462A1 (en) | 2010-09-16 |
| EP1536836A2 (en) | 2005-06-08 |
| CA2496469A1 (en) | 2004-03-04 |
| US7732489B2 (en) | 2010-06-08 |
| TW200409646A (en) | 2004-06-16 |
| EP1536836B1 (en) | 2008-03-26 |
| AR041021A1 (es) | 2005-04-27 |
| MXPA05002077A (es) | 2005-06-08 |
| US20050239894A1 (en) | 2005-10-27 |
| DK1536836T3 (da) | 2008-07-21 |
| BR0313701A (pt) | 2005-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20040321A1 (es) | Composicion topica que comprende diclofenaco | |
| AR037490A1 (es) | Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos | |
| PE20071310A1 (es) | Formulaciones liquidas de fenilefrina | |
| GT200000108A (es) | Procedimiento para la obtencion de composiciones antibacteriales. | |
| PE20050775A1 (es) | Formulaciones que comprenden multiparticulas de liberacion controlada | |
| BRPI0409185A (pt) | formulações veterinárias anti-helmìnticas tópicas | |
| BR9909796B1 (pt) | "derivados de piperidinopirimidina para aplicação tópica" | |
| MX9306708A (es) | Composiciones de espuma de lucha contra el fuego, de un solvente polar de baja viscosidad. | |
| BR0013648A (pt) | Formulação farmacêutica contendo derivado de benzamida tendo solubilidade e absortividade oral melhoradas | |
| ITMI20021392A1 (it) | Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita' | |
| BR0008405A (pt) | Composição de fator viii formulada sem a adição de albumina, uso de uma composição de fator viii, e, método de liofilizar uma formulação farmacêutica aquosa | |
| DK1299108T3 (da) | Parasiticidt præparat samt fremgangsmåde til fremstilling af dette præparat | |
| ES2151464T3 (es) | Preparacion para aplicacion externa que comprende tranilast y procedimiento para producirla. | |
| TW565461B (en) | Immunosuppressive pharmaceutical composition for external application | |
| EP1340755A4 (en) | AGENT WITH EFFECT AGAINST HELICOBACTER | |
| BRPI0510231A (pt) | composto, polimorfo cristalino, cossolvato em metanol e água, cossolvato em metanol-água, cossolvato em etanol-água, composição farmacêutica, método para administrar um agente ativo, método para preparar a forma i do snac, método para preparar a forma ii de snac, método para preparar a forma iii de snac, método para preparar a forma iv de snac, método para preparar a forma v de snac, método para preparar a forma vi de snac, composição farmacêutica e método para preparar snac amorfo | |
| BR0317340A (pt) | Formulações de hfc em solução contendo tiotrópio | |
| AR045094A1 (es) | Formulaciones liofilizadas de cci-779 | |
| BR0316187A (pt) | Formulações parasiticidas tópicas e métodos de tratamento | |
| AR039935A1 (es) | Formulacion farmaceutica de liberacion inmediata | |
| BR9810711A (pt) | Formulação tópica de pulverização antipruriginosa, e, processo para prevenção ou tratamento de prurido em um paciente | |
| AR055591A1 (es) | Una composicion topica protectora de la piel y su uso | |
| BR0113268A (pt) | Uso de sulfonas de triazinotriona para o combate de coccidioses | |
| ATE163265T1 (de) | Asserlösliche pharmazeutische zusammensetzungen, die östronderivate und kalziumsalze enthalten | |
| GT199900171A (es) | Concentrado oral de sertralina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |